Dizziness
Showing 9976 - 10000 of >10,000
Postoperative Nausea and Vomiting Trial in Rio de Janeiro (Ondansetron, Palonosetron)
Completed
- Postoperative Nausea and Vomiting
-
Rio de Janeiro, BrazilHospital Federal de Bonsucesso
Aug 8, 2017
Migraine, Headache, Dizziness Trial in San Francisco (topiramate, lactulose pill)
Withdrawn
- Migraine
- +2 more
- topiramate
- lactulose placebo pill
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 4, 2015
Endometrial Biopsy, Abnormal Uterine Bleeding Trial in Songkla (paracervical block with 1%lidocaine, 10%lidocaine spray)
Completed
- Endometrial Biopsy
- Abnormal Uterine Bleeding
- paracervical block with 1%lidocaine
- 10%lidocaine spray
-
Songkla, Hatyai, ThailandAkarawit Jitchanwichai
Feb 20, 2017
Neck Pain, Eye Strain Trial in Cadiz (EYE-CERVICAL RE-EDUCATION PROGRAM, Combined Physiotherapy Protocol)
Completed
- Neck Pain
- Eye Strain
- EYE-CERVICAL RE-EDUCATION PROGRAM
- Combined Physiotherapy Protocol
-
Cadiz, SpainFaculty of Nursing and Physiotherapy. University of Cadiz
Jun 22, 2017
OATP1B1 and CYP2C9 Genotypes on Pharmacokinetics of Bosentan
Completed
- Drug Interactions
-
Heidelberg, GermanyUniversity Hospital Heidelberg
May 3, 2017
Tumors Trial in Taiwan, United States (BI 6727, IV infusion)
Completed
- Neoplasms
- BI 6727, IV infusion
-
Beverly Hills, California
- +20 more
Oct 23, 2017
Lung Cancer, Solid Tumor Trial in Sacramento (cetuximab, erlotinib)
Completed
- Lung Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
-
Sacramento, CaliforniaUniversity of California Davis Cancer Center
Mar 27, 2017
Multiple Myeloma Trial in Worldwide (Part 1: Daratumumab, Part 2: Daratumumab, Methylprednisolone)
Completed
- Multiple Myeloma
- Part 1: Daratumumab
- +3 more
-
Boston, Massachusetts
- +6 more
Mar 30, 2018
Anemia Trial in Korea, Republic of (methoxy polyethylene glycol-epoetin beta [Mircera])
Completed
- Anemia
- methoxy polyethylene glycol-epoetin beta [Mircera]
-
Busan, Korea, Republic of
- +9 more
Jun 15, 2017
Bipolar I Disorder Trial in United States (Inhaled Placebo, Inhaled loxapine 5 mg, Inhaled loxapine 10 mg)
Completed
- Bipolar I Disorder
- Inhaled Placebo
- +2 more
-
Escondido, California
- +5 more
Jun 28, 2017
Advanced or Metastatic Solid Tumors, Advanced or Metastatic Breast Cancer Trial in Salt Lake City (Azacitidine (Vidaza),
Completed
- Advanced or Metastatic Solid Tumors
- Advanced or Metastatic Breast Cancer
- Azacitidine (Vidaza)
- Nab-paclitaxel (Abraxane)
-
Salt Lake City, UtahUniversity of Utah Huntsman Cancer Institute
Jun 27, 2017
Hodgkin Disease, Lymphoma, Non-Hodgkin, Tumors Trial (MK-8776, Gemcitabine)
Completed
- Hodgkin Disease
- +2 more
- (no location specified)
Jul 26, 2018
MDD Trial in United States (rTMS, Sham Device)
Completed
- Major Depressive Disorder
- rTMS
- Sham Device
-
Palo Alto, California
- +8 more
Feb 8, 2018
Esophageal Cancer Trial in United States (drug, procedure, radiation)
Epilepsy Trial in Bucharest (BIA 2-093 (Eslicarbazepine acetate))
Completed
- Epilepsy
- BIA 2-093 (Eslicarbazepine acetate)
-
Bucharest, RomaniaClinica de Neurologie Pediatrica, Spitalul "Alexandru Obregia"
Aug 23, 2017
Prostate Cancer Trial in Omaha (Orteronel, Orteronel Placebo, Prednisone)
GNE Myopathy, Hereditary Inclusion Body Myopathy (HIBM) Trial in Israel, United States (SA-ER 500 mg, SA-IR 500 mg)
Completed
- GNE Myopathy
- Hereditary Inclusion Body Myopathy (HIBM)
- SA-ER 500 mg
- SA-IR 500 mg
-
Los Angeles, California
- +3 more
Mar 16, 2018
Head Neck Cancer Trial in New York (biological, drug, procedure, radiation)
Completed
- Head and Neck Cancer
- bevacizumab
- +3 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jul 19, 2017
Liver Diseases, Hepatic Insufficiency Trial in Miami, Orlando (Baricitinib)
Completed
- Liver Diseases
- Hepatic Insufficiency
-
Miami, Florida
- +1 more
May 15, 2017
Alcoholism Trial (Medisorb naltrexone 380 mg, Medisorb naltrexone 190 mg)
Completed
- Alcoholism
- Medisorb naltrexone 380 mg
- Medisorb naltrexone 190 mg
- (no location specified)
Jun 8, 2017
Albinism, Inborn Errors of Metabolism, Oculocutaneous Albinism Trial run by the (Pirfenidone, Placebo)
Completed
- Albinism
- +4 more
- Pirfenidone
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 14, 2017